Two kinds of cells in grafts of pituitary pars intermedia and their probable dependence on dopamine

Neuroendocrinology
F C Iturriza

Abstract

When histological sections of noninnervated kidney grafts of pituitary pars intermedia were immunohistochemically processed for the demonstration of either alpha melanocyte-stimulating hormone or adrenocorticotropic hormone, chromophilic (dark) and chromophobic (light) cells could be detected. The latter, which were not detected in the intact intermedia, were interpreted as hyperactive cells, since they lacked secretory granules and displayed an increased nuclear area. The administration of ergocryptine prevented the development of light cells. Moreover, after chronic stress (swimming), some cells appeared less intensely granulated than dark cells. The results suggest that the pars intermedia is composed of parenchymal cells with different sensitivities to dopamine. Light cells would be subject to a greater dopamine-induced inhibitory influence than dark cells. The appearance of partially degranulated cells after stress points to a participation of the grafts in this event and indicates that innervation of the intermedia is not an indispensable condition for its contribution to stress.

Related Concepts

Muscle Innervation, Function
Structure of Pars Intermedia of Pituitary Gland
August Rats
Immunocytochemistry
Nerve Supply
Ergocryptine
Dopamine Measurement
Dopamine
POMC gene
Recombinant Corticotropin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.